Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Signaling by melatonin receptors]

L Petit1, B Guardiola, P Delagrange

  • 1CNRS UPR0415 et Université Paris 7, Institut Cochin de Génétique Moléculaire, France.

Therapie
|January 28, 1999
PubMed
Summary

Melatonin receptors, Mel1 and Mel2, are key to physiological processes. This review details their characterization and diverse signaling pathways beyond adenylyl cyclase inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Emergency room visits for asthma and the reported outcomes: The PASS survey by the CRISALIS network].

Revue des maladies respiratoires·2025
Same author

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.

ESMO open·2024
Same author

Detection of fungi in the airways of horses according to the sample site: a methodological study.

Veterinary research communications·2023
Same author

Upconversion from fluorophosphate glasses prepared with NaYF<sub>4</sub>:Er<sup>3+</sup>,Yb<sup>3+</sup> nanocrystals.

RSC advances·2022
Same author

Nucleation and growth behavior of Er<sup>3+</sup> doped oxyfluorophosphate glasses.

RSC advances·2022
Same author

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022

Area of Science:

  • Endocrinology and Molecular Biology
  • Neuroscience
  • Cell Signaling

Context:

  • Melatonin is a crucial hormone regulating circadian rhythms, hormone release, and immune responses.
  • High-affinity melatonin receptors (Mel1 and Mel2) are distributed across various organs and brain structures.
  • While Mel1 receptor-mediated adenylyl cyclase inhibition is well-studied, it doesn't fully explain melatonin's diverse effects.

Purpose:

  • To review the current understanding of melatonin receptor characterization.
  • To explore the diverse signaling mechanisms activated by melatonin receptors.
  • To provide an updated overview of melatonin receptor signal transduction.

Summary:

  • Melatonin receptors are classified into Mel1 and Mel2 groups, with known subtypes cloned and localized in various tissues.
  • Beyond adenylyl cyclase inhibition, melatonin signaling involves modulation of phospholipase C, potassium channels, and guanylyl cyclases.
  • This review synthesizes current knowledge on melatonin receptor signaling diversity.

Impact:

  • Enhances understanding of melatonin's pleiotropic physiological roles.
  • Provides a foundation for further research into melatonin receptor pharmacology and therapeutic applications.
  • Highlights the complexity of melatonin signaling pathways, suggesting novel targets for intervention.

Related Experiment Videos